News

Proteologics and GSK signed a collaboration agreement on six drug discovery projects in 2010. Proteologics CEO Josh Levine said, "Proteologics is hopeful that by the end of the

The Xopenex Inhalation Solution is specified to treat or prevent bronchospasm in patients aged six years and more with reversible obstructive airway disease. Mylan has begun the shipment

According to the study, significant improvement in scores on the International Prostate Symptom Score (IPSS) were observed upon the co-administeration of Cialis 5mg once daily with finasteride, compared

Uplyso, referred to as Elelyso (taliglucerase alfa) outside of Latin America, is approved as a long-term plant cell-based enzyme replacement therapy (ERT) for adults diagnosed with type I

The new RayStation 3.5 version includes a wide range of new features and improvements, including radiation therapy with electrons and protons, along with a Proton Beam Design module.

The firm claims that the EDC software helps researchers to freely initiate studies, which are funded by university and/or government. With the new EDC software, university researchers can

A member of the Zeltia Group and a developer of antitumor drugs of marine origin, PharmaMar will use Medidata Clinical Cloud platform to streamline its clinical trial processes.

Ranging from 0.5L bench-scale glass to 2,000L cGMP single-use production vessels, TruBio automates a wide variety of bioreactors. Optimized for DeltaV 11.3, TruBio DV continued to be powered

TTP488 prevents interaction of a material found in the Alzheimer’s patients cells, referred to as amyloid beta (Aß). The candidate is the first drug related to Receptor for